Cohance Lifesciences Limited (COHANCE.BO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Vivek Sharma CPA | Executive Chairman | -- | -- | -- |
| Dr. Sudhir Kumar Singh Ph.D. | Chief Executive Officer | -- | -- | 1965 |
| Mr. Himanshu Agarwal | Chief Financial Officer | -- | -- | 1970 |
| Ms. Cyndrella Carvalho | Head of Investor Relations | -- | -- | -- |
| Dr. K. Nagendra Babu Ph.D. | Chief Quality & Compliance Officer | -- | -- | -- |
| Mr. Gaurav Narain Bahadur | Chief Human Resources Officer | -- | -- | 1970 |
| Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju Ph.D. | MD & Director | -- | -- | -- |
| Dr. Declan Ryan Ph.D. | Chief Commercial Officer | -- | -- | -- |
| Mr. Sunder Venkatraman | Vice President of Corporate Affairs | -- | -- | -- |
Cohance Lifesciences Limited
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Cohance Lifesciences Limited engage in the end-to-end contract development and manufacturing of intermediates and active pharmaceutical ingredients in India. The coampny offers active pharmaceutical ingredients and formulations for various applications; CDMO services, a flexible and custom solutions for challenging development and manufacturing needs; and clinical, analytical, and research services. It also manufactures finished dosage formulations for pharmaceutical companies; and specialty chemicals, such as electronic chemicals. The company was formerly known as Suven Pharmaceuticals Limited and changed its name to Cohance Lifesciences Limited in May 2025. The company was founded in 1989 and is based in Hyderabad, India. Cohance Lifesciences Limited is a subsidiary of Berhyanda Limited.
Corporate Governance
Upcoming Events
August 7, 2025 at 10:59 AM UTC - August 11, 2025 at 12:00 PM UTC
Cohance Lifesciences Limited Earnings Date
Recent Events
September 9, 2022 at 12:00 AM UTC
Ex-Dividend Date